Trial NCT02811484

View at ClinicalTrials.gov 
Org. Study IDs: 1512016843

Last trial update was posted on 2017-03-03

MeSH Interventions

Dapagliflozin Exenatide

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2 Overweight

Other Conditions


Stopping Reasons

Inability to enroll due to the widespread use of both classes of drugs in patients with T2DM, including those on concomitant insulin therapy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID